Avid Bioservices Inc (CDMO)

[jbainseky]

Curlew, if you read the article this passage is important:

“Patent nonuse occurs when a patentee fails to commercialize its patent,”which may happen for a number of reasons. Some patents simply “have no present commercial value.” Sometimes licensing negotiations with competitors or strategic partners will not be mutually beneficial and will ultimately fail. Under these circumstances, the market seems to be signaling that these patents are not worth the expense and effort of commercialization. But patent nonuse can also arise from anticompetitive and strategic behaviors,where patentees deliberately suppress products or processes from the
market to benefit financially.

In your article, and others sited throughout it, technology suppression is by a single company controlling the technology through buying/licensing the patent and sitting on it to protect their business/profits. It is not (nor can it be) accomplished by an entire industry.

For the IP to fall into the last category as you surmise, some single BP, that believed that bringing the "disruptive technology" of the IP to market would not be in their best financial interest, and for $8M was able to "out-bid" all other BP who felt it would be in their financial best interest.

That just doesn't make sense. I'm sorry, but I'm going to have to go the more plausible, that the deal we have was the best they could get, and if the IP is truly as valuable as we hope, it will be realized and commercialized.

FFTT

JBAIN